X-Brain

As the global leader in stroke treatment technology, X-Brain has opened the maximum time window of stroke treatment wider and wider. Based on the cutting-edge medical research on the effect of sphenopalate ganglion stimulation on cerebral blood flow, X-Brain provides periodic, efficient, safe and controllable electrical stimulation for patients with cerebral infarction through microneedle implantation, which can effectively treat stroke patients outside the window of 8 hours. Backed by the market scale of 100 billion, X-Brain fills the treatment gap with the technical advantages of low cost, low consumable and short cycle, and gives tens of millions of patients a new life. X-Brain is committed to building the world's leading stroke treatment program, adhering to the corporate mission of saving tens of millions of `incurable` stroke patients, and improving human well-being with the power of technology.